HSF1 and ovarian cancer: Therefore, it was speculated that PGPIPN may regulate HSF1/HSP70 signal transduction and alter the expression level or activity of proteins in human ovarian cancer cells, which leads to the reduction of MDR1 and ERCC1 expression, thereby increasing the sensitivity of ovarian cancer cells to DDP.